)
Visual22 Oct 2025
Epiroc's cash spent on M&A
Neola Medical (NEOLA) investor relations material
Neola Medical Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary25 Aug, 2025
Executive summary
Achieved key clinical milestones, including initiation and first patient enrollment in the Swedish pilot study and IRB approval with agreement at Cooper Hospital for the pivotal U.S. clinical study, advancing the regulatory pathway toward FDA market authorization.
Strengthened international patent portfolio with new patents granted in China and Europe, reinforcing core technology protection for continuous lung monitoring.
Secured approximately SEK 20 million in financing through a directed share issue, attracting new institutional investors and supporting clinical development.
Recognized as a finalist for Sweden's Pioneer Prize and selected to participate in World Expo 2025, enhancing global visibility.
Financial highlights
Operating revenue for H1 2025 was SEK 4,381k, down from SEK 6,208k year-over-year; Q2 2025 revenue was SEK 2,219k.
Operating result for H1 2025 was SEK -5,740k (H1 2024: -5,579k); Q2 2025 result was SEK -3,028k.
Cash and cash equivalents at June 30, 2025, were SEK 26,513k, with no interest-bearing debt and a high equity ratio of 95%.
Operational costs for H1 2025 were slightly lower year-over-year due to reduced need for external resources.
Majority of costs for ongoing studies are expected to occur later in 2025.
Outlook and guidance
Pivotal U.S. clinical study expected to begin after completion of the Swedish pilot study, with both U.S. sites targeted to start simultaneously.
FDA and CE mark submissions planned for 2026, with approvals expected in 2026/2027.
Focus remains on clinical validation, regulatory progress, and market launch preparations, especially in the U.S.
Burn rate expected to increase as clinical validation accelerates and commercial structure preparations progress.
Ongoing efforts to expand hospital relationships and prepare for adoption in top U.S. children's hospitals.
Pilot study results impact on US pivotal study timeline
Cash runway given increasing clinical study costs
US NICU market penetration strategy
Key dependencies for U.S. pivotal study start?
Status of new patent family application in the U.S.?
Detail U.S. market penetration strategy beyond studies.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Neola Medical earnings date
Q3 20255 Nov, 2025
Next Neola Medical earnings date
Q3 20255 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Neola Medical develops medical technology for continuous monitoring of lung function in newborns. The company’s non-invasive systems are designed for use in neonatal intensive care units to improve early detection and respiratory treatment. The company operates in the healthcare technology sector. The company is headquartered in Lund, Sweden, and its shares are listed on the STO.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage